Please login to the form below

I have forgotten my password

deafness

This page shows the latest deafness news and features for those working in and with pharma, biotech and healthcare.

Pfizer spins out SpringWorks Therapeutics biotech

and a host of other complications including blindness, deafness, learning disabilities and pain.

Latest news

BioMarin's real world data sways NICE on orphan drug Vimizim

heart disease, dental and eye care, pain relief, and hearing aids and ventilating tubes to manage deafness and middle ear effusions.
Hearing loss prevention drugs expected by 2020

Report by Action on Hearing Loss launched today
NICE backs Roche's MabThera in rare autoimmune disease

indication, with ANCA-associated vasculitis an umbrella term for several related conditions that usually affect the lungs, kidneys, ears, nose or sinuses, sometimes leading to organ damage, bleeding or deafness.
Novartis wins childhood arthritis indication for Ilaris in EU

The approval adds to Ilaris' existing approvals in the EU to treat the rare inflammatory disorder cryopyrin-associated periodic syndromes (CAPS), which can lead to deafness and loss of vision, and
European approval for GSK’s meningitis vaccine Nimenrix

The form of meningitis it protects against has the potent to cause deafness, epilepsy and other neurological disordere, and it its most serious incidents can results in death.

More from news
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest Intelligence

Significant figures

The liposome technology creates a shield that keeps most of the drug out of direct contact with a patient’s blood, successfully dodging Amikacin’s severe side effects, which include deafness,
The impending threat of antibiotic resistance

Pneumonia. 1 in 3 people died. Ear infection. Caused deafness. Surgery.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Scientific Director: Great salary and bebefits

Medical Writer - (London, Brighton or Copenhagen): Competitive

Editor – Medical Education Agency – Bucks: Salary TBC

Senior Medical Writer: Great salary and benefits

Senior Medical Writer: Great salary and bebefits

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

Editorial Director – Medical Education – Oxford: Negotiable

Senior Account Manager or AD - Medical Communications: Salary TBC

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Senior Programme Executive: Salary TBC

Account Manager – Med Comms – London: Salary TBC

Editorial Team Leader or Scientific Director: £50, 000 - £55, 000 benefits

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Senior Account Manager – Med Comms – Kent: Salary TBC

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

Senior Account Manager / Account Director: Great salary and bebefits

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Subscribe to our email news alerts

PMHub

Add my company

Pegasus

At Pegasus, we specialise in helping deliver healthy messages through integrated communication programmes. In fact, inspiring healthy decisions is all...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement: Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies: Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...